CHPA Regulatory & Scientific Conference In Brief
This article was originally published in The Tan Sheet
OTC monograph finalization may never end, FDA exec suggests; agency official advises coloring inside the monograph lines; OTC adverse event reports fell about 19% in 2011; supplement AER practices can mitigate rising insurance rates.
You may also be interested in...
Pernix, SEEK prep new cough med; FDA warns Quadex over herpes reference; NuMe progresses on prebiotic program; Creative Edge Nutrition expands; Reaction Nutrition records lacking; more news In Brief.
FDA’s dietary supplement program chief raised eyebrows at a botanical products conference citing low estimates on rates of compliance with the good manufacturing practices final rule and the new dietary ingredient notification requirements, as well as adverse event reporting.
FDA softens disclaimer for green tea QHC; Formulife/Purus covers spectrum of violations; NAD refers Schick case to FTC; Genomma drops Prestige Brands board bid.